AdaptHealth Corp. (NASDAQ:AHCO) Shares Purchased by Royce & Associates LP

Royce & Associates LP raised its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 29.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 1,002,755 shares of the company’s stock after acquiring an additional 225,350 shares during the period. Royce & Associates LP’s holdings in AdaptHealth were worth $9,546,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in AHCO. Principal Financial Group Inc. boosted its stake in AdaptHealth by 39.7% in the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock worth $6,106,000 after buying an additional 154,434 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of AdaptHealth by 727.4% in the third quarter. Victory Capital Management Inc. now owns 141,507 shares of the company’s stock worth $1,589,000 after acquiring an additional 124,404 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of AdaptHealth by 33.8% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 27,814 shares of the company’s stock valued at $312,000 after buying an additional 7,031 shares during the period. CIBC Asset Management Inc purchased a new stake in AdaptHealth during the third quarter valued at about $122,000. Finally, Mutual of America Capital Management LLC increased its position in AdaptHealth by 23.8% during the 3rd quarter. Mutual of America Capital Management LLC now owns 15,893 shares of the company’s stock worth $178,000 after purchasing an additional 3,052 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Truist Financial increased their price objective on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Royal Bank of Canada boosted their price objective on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Canaccord Genuity Group raised their target price on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Robert W. Baird lifted their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Finally, UBS Group decreased their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $13.80.

AdaptHealth Price Performance

AHCO stock opened at $9.88 on Wednesday. The company has a market capitalization of $1.33 billion, a PE ratio of -5.99, a P/E/G ratio of 1.08 and a beta of 1.30. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The stock’s 50 day moving average is $10.02 and its two-hundred day moving average is $10.20. AdaptHealth Corp. has a 52-week low of $8.35 and a 52-week high of $11.90.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.